Merck, known as MSD outside the U.S. and Canada, launched Your Hive of Whole Health on September 18, 2026 — a multi-year ...

OS Therapies, Inc., a Rockville, Maryland- and New York-based clinical-stage oncology company, announced on September 17, ...

Rachel Chiaverelli, PhD, has joined GSK as Executive Director, Oncology Early Translational Biomarkers, after nearly four ...

Velocity Clinical Research has appointed Justin Starzyk as Chief Executive Officer, succeeding Paul Evans, who is ...

Claritev has appointed Ben Letham to its Board of Directors, effective September 14, 2026. “Claritev is fortunate to add a ...

Penn Medicine has named Julia Puchtler Executive Vice President and Chief Financial Officer of the University of Pennsylvania Health System (UPHS), ...

The University of Maryland School of Public Health announced on September 15, 2026 a $2.5 million grant from the National Institutes of Health to ...

Georgiamune, a Gaithersburg, Maryland-based clinical-stage biotech with roughly 30 employees, has raised approximately $92.69 million in Series B financing ...

Autolus Therapeutics plc, the commercial-stage biopharmaceutical company with dual headquarters in London and Gaithersburg, Maryland, announced on ...

Jazz Pharmaceuticals plc, the Dublin-headquartered biopharma with a major U.S. hub in Philadelphia, announced on September 15, 2026 that it completed its acquisition of Actio Biosciences, Inc. for an ...

TEDCO, Maryland’s economic engine for technology companies, announced a $25,000 investment in Sirius Biotech Ventures on September 15, 2026, through ...